Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Ind Med ; 52(6): 464-70, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19296550

RESUMO

BACKGROUND: Asbestos fibers are known to accumulate in lung parenchyma and thoracic lymph nodes, but their presence and translocation into the extrapulmonary tissues need clarification. We assessed the presence of asbestos in the para-aortic (PA) and mesenteric (ME) lymph nodes. METHODS: PA and ME lymph nodes and lung tissue from 17 persons who underwent medicolegal autopsy for suspicion of asbestos-related disease and from five controls were analyzed for asbestos fibers using transmission electron microscopy. RESULTS: High concentrations of amphibole asbestos fibers were detected in several lung tissue samples and in the respective PA and ME lymph nodes. The mean concentration for the 10 persons with a lung asbestos content of >/=1 million fibers/g of dry tissue (f/g) was 0.85 (<0.05-4.36) million f/g in the PA lymph nodes and 0.55 (<0.02-2.86) million f/g in the ME lymph nodes. The respective mean values for the 12 persons with a lung asbestos concentration of <1 million f/g were 0.07 for the PA lymph nodes and 0.03 million f/g for the ME nodes. The lung asbestos burden that predicted the detection of asbestos in abdominal lymph nodes was 0.45 million f/g. CONCLUSIONS: In addition to their accumulation in lung tissue, asbestos fibers also collect in the retroperitoneal and the mesenteric lymph nodes. Even low-level occupational exposure results in the presence of crocidolite, amosite, anthophyllite, tremolite, or chrysotile in these abdominal lymph nodes. Our results support the hypothesis of lymph drainage as an important translocation mechanism for asbestos in the human body.


Assuntos
Amianto/análise , Asbestose/patologia , Pulmão/química , Linfonodos/química , Doenças Profissionais/patologia , Idoso , Idoso de 80 Anos ou mais , Amiantos Anfibólicos/análise , Asbestose/metabolismo , Carga Corporal (Radioterapia) , Humanos , Exposição por Inalação/efeitos adversos , Exposição por Inalação/análise , Pulmão/patologia , Pulmão/ultraestrutura , Linfonodos/patologia , Linfonodos/ultraestrutura , Masculino , Mesentério , Pessoa de Meia-Idade , Fibras Minerais/análise , Doenças Profissionais/metabolismo , Exposição Ocupacional , Espaço Retroperitoneal
2.
BMJ Case Rep ; 20092009.
Artigo em Inglês | MEDLINE | ID: mdl-21686706

RESUMO

We describe a case history of a former insulator who developed concomitant retroperitoneal and pleural fibrosis. In his work, the patient had been exposed on a daily basis to asbestos dust while demolishing and installing pipeline insulations. The heavy asbestos exposure was confirmed by a high level of asbestos content in his autopsy lung sample. We propose that both retroperitoneal fibrosis and diffuse pleural thickening were induced in our patient by an abundant amount of amphibole asbestos fibres found in his lung and retroperitoneal tissues.

3.
Addiction ; 98(3): 365-8, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12603236

RESUMO

Four deaths following the ingestion of moclobemide and MDMA ('ecstasy') are described. The probable cause of death in each case was serotonin syndrome as a result of an interaction between the two drugs. As none of the victims had been prescribed moclobemide it seems that each had taken the drug to enhance the effects of MDMA, with fatal consequences. Warnings are needed against misinformed attempts to potentiate the pharmacological effects of illicit drugs.


Assuntos
Alucinógenos/intoxicação , Moclobemida/intoxicação , Inibidores da Monoaminoxidase/intoxicação , N-Metil-3,4-Metilenodioxianfetamina/intoxicação , Serotoninérgicos/intoxicação , Síndrome da Serotonina/induzido quimicamente , Adolescente , Adulto , Interações Medicamentosas , Overdose de Drogas , Evolução Fatal , Feminino , Alucinógenos/sangue , Humanos , Masculino , Moclobemida/sangue , Inibidores da Monoaminoxidase/sangue , N-Metil-3,4-Metilenodioxianfetamina/sangue , Serotoninérgicos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...